H.C. Wainwright Thinks AzurRx BioPharma Inc’s Stock is Going to Recover

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on AzurRx BioPharma Inc (NASDAQ: AZRX), with a price target of $6. The company’s shares closed yesterday at More »

The CMO of Xencor Inc is Exercising Options

Today it was reported that the CMO of Xencor Inc (NASDAQ: XNCR), Paul A. Foster, exercised options to sell 36,341 XNCR shares at $11.05 a share, for a total transaction value of More »